Farther Finance Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.22M Sell
11,074
-167
-1% -$16.1K 0.01% 1018
2026
Q2
$879K Sell
11,241
-2,092
-16% -$143K 0.01% 1180
2026
Q1
$872K Buy
13,333
+918
+7% +$64.7K 0.01% 1054
2025
Q4
$836K Buy
12,415
+861
+7% +$57.9K 0.01% 991
2025
Q3
$847K Buy
11,554
+2,832
+32% +$188K 0.01% 810
2025
Q2
$454K Buy
8,722
+3,217
+58% +$183K 0.01% 953
2025
Q1
$341K Buy
5,505
+4,741
+621% +$275K 0.01% 977
2024
Q4
$36.5K Sell
764
-856
-53% -$43.9K ﹤0.01% 1811
2024
Q3
$92.7K Buy
1,620
+1,028
+174% +$58.9K ﹤0.01% 1337
2024
Q2
$30.8K Buy
592
+455
+332% +$20K ﹤0.01% 1607
2024
Q1
$5.66K Sell
137
-116
-46% -$4.35K ﹤0.01% 2010
2023
Q4
$9.35K Buy
253
+223
+743% +$8.4K ﹤0.01% 1639
2023
Q3
$1.15K Hold
30
– – ﹤0.01% 2043
2023
Q2
$1.08K Buy
30
+25
+500% +$853 ﹤0.01% 1950
2023
Q1
$191 Buy
+5
New +$235 ﹤0.01% 2203

Other funds holding HALO

Farther Finance Advisors's HALO Position: Q3 2026 in Review

Farther Finance Advisors reduced its Halozyme (HALO) stake by 1.5% in Q3 2026, selling an estimated $16.1K and leaving 11,074 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #1018.

Farther Finance Advisors first reported a position in HALO in Q1 2023 and has held it in 15 quarters since. 31 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Farther Finance Advisors held 11,074 shares of Halozyme worth $1.22M as of Q3 2026.
  • Farther Finance Advisors sold 167 Halozyme shares in Q3 2026, an estimated $16.1K.
  • Halozyme made up 0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1018 holding.
  • Farther Finance Advisors first reported a position in Halozyme in Q1 2023 and has held it in 15 quarters since.
  • 31 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.